Research Article

Prognostic Value of Excision Repair Cross-Complementing mRNA Expression in Gastric Cancer

Table 4

The prognostic value of the mRNA expression of ERCC in HER2 status GC patients.

GenesHER2 statuscasesHR (95% CI)P-value

ERCC1negative2980.75 (0.56–1.01)0.054
positive2950.71 (0.51–0.98)0.039
ERCC2negative2980.76 (0.56–1.03)0.073
positive2950.72 (0.54–0.95)0.022
ERCC3negative2980.8 (0.59–1.09)0.15
positive2951.45 (1.1–1.92)0.0075
ERCC4negative2981.27 (0.94–1.72)0.11
positive2951.52 (1.13–2.05)0.0059
ERCC5negative2980.86 (0.64–1.14)0.29
positive2951.45 (1.1–1.9)0.0082
ERCC6negative2981.22 (0.92–1.62)0.18
positive2951.27 (0.94–1.71)0.11
ERCC8negative1950.79 (0.54–1.15)0.21
positive1531.8 (1.19–2.74)0.0052

Notes. ERCC, excision repair cross-complementing; GC, gastric cancer; HR, hazard ratio; CI, confidence interval.